Ingredient Science

Saw Palmetto: What The Evidence Actually Shows

By the Prostacyl Editorial Team · September 27, 2026 · 7 min read

In Short

Saw palmetto has one of the most extensive, and genuinely mixed, research histories of any ingredient in the prostate-support category.

Understanding both the older favorable trials and the more recent, less favorable evidence helps set realistic expectations.

Where saw palmetto's reputation comes from

Earlier trials built saw palmetto's strong reputation in this category. A systematic review published in JAMA, pooling 18 studies, reported improvements in urinary flow and nighttime urination for men with BPH symptoms. Separately, a large head-to-head trial found a standardized saw palmetto extract (Permixon) performed comparably to the prescription drug finasteride over the study period.

What more recent evidence shows

A 2023 Cochrane review covering 27 randomized controlled trials and 4,656 participants reached a considerably less favorable conclusion: saw palmetto used alone provides little or no benefit for urinary symptoms associated with benign prostate enlargement, compared to placebo. The National Center for Complementary and Integrative Health's current published assessment aligns with that conclusion, describing saw palmetto as probably not helpful for BPH-related urinary symptoms when used on its own.

Why this matters for a nine-ingredient formula: this evidence picture concerns saw palmetto used alone, not necessarily in combination with other ingredients like pygeum — but it also means no combination-formula research exists that would let us extend pygeum's more favorable evidence to cover saw palmetto's weaker standalone picture.

Pygeum's comparatively stronger evidence

Pygeum africanum, the second-highest-dosed ingredient in this formula, has its own, more consistently favorable research base. A Cochrane Database systematic review pooling 18 randomized trials found men treated with pygeum were more than twice as likely to report symptom improvement compared to placebo.

The distinction that matters most

All of this research examines the individual ingredients — largely as standardized extracts studied on their own — not the specific formula, extraction methods, or dosing combination used in any particular finished product, including Prostacyl. Ingredient-level research is not the same as evidence for a specific commercial product.

Applying this to Prostacyl

Saw palmetto (300mg) and pygeum (200mg) are the two highest-dosed ingredients in Prostacyl's nine-ingredient formula. See our full review for how this evidence picture factors into our overall assessment.

About this article: written by the Prostacyl Editorial Team for general information. It is not medical advice. This is an independent site and earns a commission on purchases through links to the official seller — see our editorial standards.